KINETA, INC./DE

Profile

Company Names

KINETA, INC./DE
YUMANITY THERAPEUTICS, INC.
PROTEOSTASIS THERAPEUTICS, INC.
PROTEOSTASIS THERAPEUTICS INC

Addresses

219 TERRY AVE. N., SUITE 300, SEATTLE, WA 98109-5208

40 GUEST STREET, SUITE 4410, BOSTON, MA 02135

200 TECHNOLOGY SQUARE, CAMBRIDGE, MA 02139

200 TECHNOLOGY SQUARE, SUITE 402, CAMBRIDGE, MA 02139

Phone Numbers

(206) 378-0400
617-409-5300
617-225-0096

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$148,722,887.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-10-03 
$0.00 
$2,893,176.00 
$2,893,176.00 
 
5
2022-12-16 
$7,500,000.00 
$30,000,000.00 
$22,500,000.00 
Equity 
4
2020-12-22 
$33,599,895.00 
$33,599,895.00 
$0.00 
Equity 
3
2015-09-01 
$21,999,992.00 
$27,999,992.00 
$6,000,000.00 
Equity 
2
2014-07-31 
$15,000,000.00 
$15,000,000.00 
$0.00 
Debt 
1
2008-08-15 
$70,623,000.00 
$81,760,000.00 
$11,137,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEITH 
A. 
BAKER 
EXECUTIVE OFFICER
KEITH A. 
 
BAKER 
EXECUTIVE OFFICER
RAYMOND 
 
BARTOSZEK 
DIRECTOR
MEENU 
 
CHHABRA 
EXECUTIVE OFFICER, DIRECTOR
N. ANTHONY 
 
COLES 
EXECUTIVE OFFICER, DIRECTOR
KIMBERLEE 
C. 
DRAPKIN 
DIRECTOR
SCOTT 
J. 
DYLLA 
DIRECTOR
MARION 
R. 
FOOTE 
DIRECTOR
MARION R. 
 
FOOTE 
DIRECTOR
THIERRY 
 
GUILLAUDEUX 
EXECUTIVE OFFICER
MARKUS 
 
HAEBERLEIN 
EXECUTIVE OFFICER
SHAWN 
P. 
IADONATO 
EXECUTIVE OFFICER, DIRECTOR
PAULINE 
 
KENNY 
EXECUTIVE OFFICER
STEPHEN 
 
KNIGHT, M.D. 
DIRECTOR
PAULASH 
 
MOHSEN 
EXECUTIVE OFFICER
WALTER 
 
NEWMAN 
EXECUTIVE OFFICER
RICHARD 
 
PETERS 
DIRECTOR, EXECUTIVE OFFICER
CRAIG 
W. 
PHILIPS 
EXECUTIVE OFFICER
CRAIG W. 
 
PHILIPS 
EXECUTIVE OFFICER
CECIL 
B. 
PICKETT 
DIRECTOR
PETER 
H. 
REINHART 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BRIGITTE 
 
ROBERTSON 
EXECUTIVE OFFICER
PAULINE 
JEN 
RYAN 
EXECUTIVE OFFICER
LAUREN 
 
SILVERMAN, PH.D. 
DIRECTOR
HENRY 
B. 
SKINNER 
DIRECTOR
JANET 
 
SMART 
EXECUTIVE OFFICER
NADIA 
 
USTARIZ 
EXECUTIVE OFFICER
CONOR 
 
WALSHE 
DIRECTOR
ALAN 
 
WALTS, PH.D. 
DIRECTOR
LYNNE 
 
ZYDOWSKY 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-10-03 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-16 
D
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-07-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-31 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2008-08-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
JEFFERIES LLC
IRENA MELNIKOVA
LEERINK PARTNERS LLC